Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Apr;22(4):688-693.
doi: 10.1111/dom.13912. Epub 2019 Dec 9.

Increased proportion of time in hybrid closed-loop "Auto Mode" is associated with improved glycaemic control for adolescent and young patients with adult type 1 diabetes using the MiniMed 670G insulin pump

Affiliations

Increased proportion of time in hybrid closed-loop "Auto Mode" is associated with improved glycaemic control for adolescent and young patients with adult type 1 diabetes using the MiniMed 670G insulin pump

Sara H Duffus et al. Diabetes Obes Metab. 2020 Apr.

Abstract

The Medtronic MiniMed 670G system delivers insulin to patients with type 1 diabetes mellitus (T1DM) using either its hybrid closed-loop (HCL) "Auto Mode" feature or an open-loop mode. In this retrospective, cross-sectional analysis, we quantified the association between time in Auto Mode and both haemoglobin A1c (HbA1c) and time in range (TIR, sensor glucose 70-180 mg/dL) among 96 paediatric and young adult patients with T1DM. The median percentage time in Auto Mode was 38.5% (interquartile range 0%-64%). The percentage time in Auto Mode significantly correlated with HbA1c after adjustment for covariables (β = -0.008, P = 0.014). Each daily 3.4-h increase in Auto Mode time was associated with a 0.1% decrease in HbA1c. Auto Mode time was also correlated with TIR after adjustment for covariables (β = 0.14, P = 0.02): for each daily 8.6-h increase in Auto Mode time, TIR increased by 5%. While Auto Mode use was low, increased time in Auto Mode was associated with a significantly lower HbA1c and increased TIR. These findings emphasize the importance of identifying strategies to improve the ease of use of HCL systems.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST

The authors have no conflict of interest to report.

Figures

FIGURE 1
FIGURE 1
Participant characteristics. Violin plots depict the frequency distribution of the data, with wider sections representing a higher density of participants and narrower sections representing a lower density of participants. Solid vertical line represents zero participants. Additional data depicted in the violin plot include median (thick dotted line) and interquartile range (thin dotted lines), see Table S1 (Supporting Information) for numeric median and interquartile range values. Delta HbA1c depicts change in HbA1c from just before initiation of MiniMed 670G use and time of data collection. Abbreviations: BG, blood glucose; HbA1c, haemoglobin A1c; SG, sensor glucose; TIR, time in range
FIGURE 2
FIGURE 2
Bivariate and multivariate linear regression analysis. A, Scatterplot depicting bivariate analysis of the effect of Auto Mode time (%) on HbA1c (%). B, Scatterplot depicting bivariate analysis of effect of Auto Mode time (%) on TIR (%). C, Auto Mode time and sensor wear time prediction of HbA1c. Scatterplot depicting predicted HbA1c from a linear model using sensor wear time and Auto Mode time as predictors. Light blue shaded points represent higher predicted HbA1c, dark blue shaded points represent lower predicted HbA1c. D, Correlates with HbA1c and TIR in multilinear regression analysis. Abbreviations: BG, blood glucose; HbA1c, haemoglobin A1c; SG, sensor glucose; TIR, time in range. *Significant P <0.05

Similar articles

Cited by

References

    1. Messer LH, Forlenza GP, Sherr JL, et al. Optimizing hybrid closed-loop therapy in adolescents and emerging adults using the MiniMed 670G system. Diabetes Care. 2018;41:789–796. - PMC - PubMed
    1. Stone MP, Agrawal P, Chen X, et al. Retrospective analysis of 3-month real-world glucose data after the MiniMed 670G system commercial launch. Diabetes Technol Ther. 2018;20:689–692. - PubMed
    1. Garg SK, Weinzimer SA, Tamborlane WV, et al. Glucose outcomes with the in-home use of a hybrid closed-loop insulin delivery system in adolescents and adults with type 1 diabetes. Diabetes Technol Ther. 2017; 19:155–163. - PMC - PubMed
    1. Forlenza GP, Pinhas-Hamiel O, Liljenquist DR, et al. Safety evaluation of the MiniMed 670G system in children 7–13 years of age with type 1 diabetes. Diabetes Technol Ther. 2019;21:11–19. - PMC - PubMed
    1. Miller KM, Foster NC, Beck RW, et al. Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange Clinic Registry. Diabetes Care. 2015;38:971–978. - PubMed

Publication types